Loading clinical trials...
Loading clinical trials...
Efficacy of Twice Daily Applications of LEO 124249 Ointment 30mg/g for 12 Weeks to Subjects With Alopecia Areata
Conditions
Interventions
LEO 124249
Vehicle
Locations
2
United States
Northwestern University
Evanston, Illinois, United States
The Icahn School of Medicine, Mount Sinai Hospital
New York, New York, United States
Start Date
January 1, 2016
Primary Completion Date
December 1, 2016
Completion Date
December 1, 2016
Last Updated
March 6, 2025
NCT07029711
NCT06826196
NCT06562270
NCT07133308
NCT06327581
NCT07023302
Lead Sponsor
LEO Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions